Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NTRA

Natera Inc

Sep 12 • 04:00PM ET

125.12

Dollar change +1.29
Percentage change 1.04	%

Healthcare • Diagnostics & Research • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VB XBI VXF VBK IBB IWP SCHA IWF ARKG

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.47	Insider Own	6.03%	Shs Outstand	119.58M	Perf Week	6.49%
Market Cap	15.47B	Forward P/E	-	EPS next Y	-1.16	Insider Trans	-5.47%	Shs Float	116.22M	Perf Month	5.13%
Income	-292.12M	PEG	-	EPS next Q	-0.57	Inst Own	95.49%	Short Float	6.37%	Perf Quarter	11.12%
Sales	1.36B	P/S	11.37	EPS this Y	47.96%	Inst Trans	1.73%	Short Ratio	5.26	Perf Half Y	40.65%
Book/sh	6.78	P/B	18.45	EPS next Y	41.08%	ROA	-21.13%	Short Interest	7.40M	Perf Year	129.28%
Cash/sh	7.17	P/C	17.44	EPS next 5Y	-	ROE	-40.78%	52W Range	36.90 - 124.97	Perf YTD	99.74%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-11.28%	ROI	-24.73%	52W High	0.12%	Beta	1.52
Dividend TTM	-	Quick Ratio	4.01	Sales past 5Y	33.95%	Gross Margin	53.85%	52W Low	239.08%	ATR (14)	5.00
Dividend Ex-Date	-	Current Ratio	4.14	EPS Y/Y TTM	48.84%	Oper. Margin	-23.06%	RSI (14)	61.71	Volatility	4.53% 3.90%
Employees	3293	Debt/Eq	0.52	Sales Y/Y TTM	46.13%	Profit Margin	-21.47%	Recom	1.45	Target Price	130.26
Option/Short	Yes / Yes	LT Debt/Eq	0.41	EPS Q/Q	68.71%	Payout	-	Rel Volume	0.82	Prev Close	123.83
Sales Surprise	20.51%	EPS Surprise	56.44%	Sales Q/Q	58.13%	Earnings	Aug 08 AMC	Avg Volume	1.41M	Price	125.12
SMA20	4.98%	SMA50	11.68%	SMA200	37.79%	Trades		Volume	1,154,697	Change	1.04%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-24	Resumed	Jefferies	Buy	$142
Apr-08-24	Resumed	Craig Hallum	Buy	$117
Feb-20-24	Downgrade	Raymond James	Strong Buy → Outperform	$68 → $85
Dec-29-23	Reiterated	BTIG Research	Buy	$75 → $85
Dec-14-23	Initiated	Guggenheim	Buy	$70
Dec-13-23	Initiated	Wolfe Research	Outperform	$70
Nov-13-23	Upgrade	Raymond James	Outperform → Strong Buy	$68
Sep-28-23	Initiated	Bernstein	Mkt Perform	$48
Jul-05-23	Resumed	JP Morgan	Overweight	$85
May-05-23	Initiated	UBS	Buy	$76
Jan-18-23	Upgrade	Raymond James	Mkt Perform → Outperform	$58
Aug-25-22	Initiated	Credit Suisse	Outperform	$70
Apr-25-22	Initiated	Stephens	Overweight	$54
Mar-08-22	Initiated	Goldman	Buy	$90
Jan-06-22	Resumed	Piper Sandler	Overweight	$110
Oct-15-21	Resumed	Cowen	Outperform	$150
Jun-15-21	Initiated	Raymond James	Mkt Perform
May-25-21	Initiated	Wells Fargo	Overweight	$110
Jan-28-21	Initiated	Truist	Buy	$143
Oct-08-20	Initiated	BTIG Research	Buy	$90

Show Previous Ratings

Sep-11-24 05:59AM	Natera (NTRA) Continued its Incremental Strong Results (Insider Monkey)
Sep-09-24 11:42AM	DNA Testing Stock Taps AI Amid 85% Surge (Investor's Business Daily)
Sep-08-24 08:22PM	Natera to Present New Signatera Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival (Business Wire)
Sep-06-24 10:24AM	What Makes Natera (NTRA) an Investment Bet? (Insider Monkey)
Sep-03-24 02:37AM	Natera (NTRA) Rose After Revenues And Profit Margins Beat Estimates (Insider Monkey)
11:48AM	Loading…
Aug-31-24 11:48AM	Billionaire Stan Druckenmiller Is Betting On Natera, Inc. (NTRA) (Insider Monkey)
Aug-29-24 02:07PM	The Committee's Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos (CNBC TV)
Aug-28-24 09:00AM	Natera to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-27-24 03:19PM	PepsiCo, Inc. (PEP): Among Morgan Stanleys Highest Conviction Stocks (Insider Monkey)
03:16PM	Natera, Inc. (NTRA): Among Morgan Stanley's Highest Conviction Stocks (Insider Monkey)
Aug-17-24 01:01AM	Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Aug-10-24 01:01AM	Decoding Natera Inc (NTRA): A Strategic SWOT Insight (GuruFocus.com)
Aug-09-24 09:46AM	Q2 2024 Natera Inc Earnings Call (Thomson Reuters StreetEvents) +6.38%
Aug-08-24 07:00PM	Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics (Zacks) +7.31%
05:19PM	Natera: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Natera Reports Second Quarter 2024 Financial Results (Business Wire)
Aug-06-24 09:00AM	Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-30-24 04:05PM	Natera to Report its Second Quarter 2024 Results on August 8, 2024 (Business Wire) -5.80%
Jul-29-24 10:53AM	Natera touts positive results for Merkel cell carcinoma surveillance test (Medical Device Network)
Jul-27-24 01:00AM	Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Jul-26-24 08:00AM	New MultiCenter Prospective Study Demonstrates Signatera's Clinical Utility in Merkel Cell Carcinoma (Business Wire)
Jul-25-24 10:02AM	Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jul-18-24 01:00AM	Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com) -8.35%
Jul-08-24 09:00AM	The 3 Best Gene Editing Stocks to Buy in July 2024 (InvestorPlace)
Jul-03-24 08:53AM	Natera (NTRA) Soared After a 43% Increase In Revenue (Insider Monkey)
07:00AM	Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy (Business Wire)
05:30AM	Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA) (GuruFocus.com)
Jun-27-24 07:00AM	Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer (Business Wire)
Jun-19-24 03:10AM	Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Jun-17-24 07:00AM	Natera Launches Differentiated New Feature for Prospera Heart Test, Enhancing Detection of Rejection for Transplant Patients (Business Wire)
02:25PM	Loading…
Jun-10-24 02:25PM	Final Trades: Amazon, Natera and KKR (CNBC TV)
Jun-03-24 08:00AM	Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
02:42AM	Natera (NTRA) Raised Initial 2024 Guidance in Q1 (Insider Monkey)
Jun-01-24 03:24AM	Director Gail Marcus Sells 2,000 Shares of Natera Inc (NTRA) (GuruFocus.com)
May-31-24 03:13AM	Director Rowan Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
May-30-24 08:00AM	Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024 (Business Wire)
May-23-24 04:05PM	Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
07:30AM	Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting (Business Wire)
May-18-24 03:00AM	Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
May-16-24 05:23PM	Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia)
May-11-24 01:02AM	Decoding Natera Inc (NTRA): A Strategic SWOT Insight (GuruFocus.com)
May-10-24 04:01PM	Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise (Investor's Business Daily) +10.19%
01:58PM	Stocks to Watch Friday: TSMC, Novavax, Nvidia, Goldman Sachs (The Wall Street Journal)
12:24PM	Natera Inc (NTRA) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
12:17PM	Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024 (Associated Press Finance)
12:04PM	Natera, Inc. (NASDAQ:NTRA) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:48AM	Natera Stock Charges Higher. Positive Cash Flow Arrived Early. (Barrons.com)
07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
May-09-24 06:30PM	Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:47PM	Natera: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Natera Reports First Quarter 2024 Financial Results (Business Wire)
May-03-24 08:00AM	New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera in Breast Cancer (Business Wire)
May-02-24 02:14PM	NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:50AM	Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
02:49AM	Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
May-01-24 04:05PM	Natera to Report its First Quarter 2024 Results on May 9 (Business Wire)
07:00AM	Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage (Business Wire)
Apr-27-24 02:42AM	Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (GuruFocus.com)
Apr-26-24 06:32PM	10 Cathie Wood Stocks Insiders are Selling (Insider Monkey)
Apr-24-24 08:36AM	Natera (NTRA) Rose on Momentum in the Oncology Market (Insider Monkey)
02:38AM	Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
02:38AM	CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Apr-22-24 08:00AM	Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications (Business Wire)
Apr-18-24 02:05AM	Insider Sell: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Apr-17-24 08:31AM	TipRanks Perfect 10 List: Analysts See Opportunity in These 2 Top-Scoring Stocks (TipRanks)
Apr-11-24 08:00AM	Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation (Business Wire)
Apr-09-24 07:37AM	11 Best Biotech ETFs To Buy (Insider Monkey)
Apr-08-24 08:00AM	Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera Heart dd-cfDNA Test for Heart Transplant Recipients (Business Wire)
Apr-05-24 07:00AM	Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer (Business Wire)
05:15AM	Is Natera (NTRA) On The Cusp Of Being Cash Flow Positive? (Insider Monkey)
01:51AM	Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Apr-01-24 08:00AM	Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer (Business Wire)
Mar-21-24 10:25AM	11 Best Healthcare ETFs To Buy Now (Insider Monkey)
Mar-20-24 05:46AM	Will Natera (NTRA) Continue to Deliver Solid Topline Growth? (Insider Monkey)
Mar-18-24 03:39PM	Genetic Testing Stock Nears Buy Point After Earnings Gap-Up And 45% Gain (Investor's Business Daily)
07:00AM	Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera in Stage II Colorectal Cancer (Business Wire)
Mar-14-24 08:00AM	New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease (Business Wire)
Mar-12-24 08:00AM	Natera to Present New Data at the 2024 SGO Annual Meeting on Womens Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers (Business Wire)
Mar-11-24 02:22PM	Final Trades: Natera, Disney, Chubb and ASML Holding (CNBC TV)
Mar-08-24 01:31AM	SEC and Chief Legal Officer Daniel Rabinowitz Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Mar-07-24 08:00AM	Natera Announces Commercial Coverage for Prospera Kidney and Prospera Heart from a Top BCBS Plan (Business Wire)
Mar-04-24 12:00PM	What Makes Natera (NTRA) a Strong Momentum Stock: Buy Now? (Zacks)
Mar-01-24 12:09AM	Decoding Natera Inc (NTRA): A Strategic SWOT Insight (GuruFocus.com)
Feb-29-24 11:06AM	Q4 2023 Natera Inc Earnings Call (Thomson Reuters StreetEvents) +12.98%
08:12AM	Natera, Inc. (NASDAQ:NTRA) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:00AM	Natera to Participate in March Investor Conferences (Business Wire)
Feb-28-24 06:30PM	Compared to Estimates, Natera (NTRA) Q4 Earnings: A Look at Key Metrics (Zacks)
04:32PM	Natera Inc (NTRA) Reports Significant Revenue Growth and Improved Gross Margins in Full Year 2023 (GuruFocus.com)
04:05PM	Natera Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-27-24 08:12AM	Natera (NTRA) Management Increased Full Year Guidance (Insider Monkey)
08:00AM	Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests (Business Wire)
01:07AM	Natera secures Medicare coverage for cancer test in 2 new indications (MedTech Dive)
Feb-26-24 07:00AM	Medicare Extends Coverage of Nateras Signatera MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer (Business Wire) +5.29%
Feb-20-24 08:00AM	Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call (Business Wire)
Feb-17-24 12:07AM	Natera Inc Director Herm Rosenman Sells 93,901 Shares (GuruFocus.com)
Feb-06-24 04:00PM	3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List (InvestorPlace)
Feb-05-24 08:00AM	New Study Validates Signatera in Endometrial Cancer (Business Wire)
Feb-02-24 11:02PM	Insider Sell: CFO Michael Brophy Sells 22,281 Shares of Natera Inc (GuruFocus.com)
Jan-31-24 05:02PM	Insider Sell: CFO Michael Brophy Sells 3,235 Shares of Natera Inc (GuruFocus.com)

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chapman Steven Leonard	CEO AND PRESIDENT	Aug 15 '24	Sale	118.91	5,583	663,895	200,710	Aug 16 09:40 PM
Sheena Jonathan	CO-FOUNDER	Aug 15 '24	Sale	121.01	12,000	1,452,125	287,441	Aug 16 09:40 PM
STEVEN L CHAPMAN	Officer	Aug 15 '24	Proposed Sale	118.91	5,583	663,895		Aug 15 04:32 PM
Sheena Jonathan	CO-FOUNDER	Aug 12 '24	Sale	113.82	2,700	307,314	299,441	Aug 14 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Aug 13 '24	Sale	116.67	3,956	461,547	114,606	Aug 14 09:05 PM
Sheena Jonathan	Director	Aug 12 '24	Proposed Sale	117.68	22,800	2,683,200		Aug 12 10:40 AM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Aug 08 '24	Option Exercise	5.40	190,000	1,025,107	1,480,648	Aug 09 09:40 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jul 29 '24	Sale	102.77	1,057	108,623	206,400	Jul 31 09:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Jul 29 '24	Sale	102.77	1,196	122,908	112,441	Jul 31 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Jul 31 '24	Option Exercise	5.40	100	540	108,562	Jul 31 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Jul 29 '24	Sale	102.77	929	95,469	108,462	Jul 31 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jul 29 '24	Sale	102.77	4,084	419,695	206,293	Jul 31 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 31 '24	Sale	99.65	1,866	185,947	71,955	Jul 31 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 29 '24	Sale	102.77	1,238	127,224	73,821	Jul 31 09:05 PM
MICHAEL BURKES BROPHY	Officer	Jul 31 '24	Proposed Sale	97.75	1,866	182,402		Jul 31 04:17 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 24 '24	Sale	105.53	918	96,877	76,500	Jul 26 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 26 '24	Sale	102.18	751	76,737	75,059	Jul 26 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 25 '24	Sale	105.29	690	72,650	75,810	Jul 26 09:40 PM
MICHAEL BURKES BROPHY	Officer	Jul 26 '24	Proposed Sale	102.15	751	76,715		Jul 26 04:17 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 22 '24	Sale	105.16	1,059	111,364	77,917	Jul 23 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 23 '24	Sale	107.40	499	53,592	77,418	Jul 23 09:40 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Jul 22 '24	Sale	105.16	549	57,733	113,637	Jul 23 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Jul 22 '24	Sale	105.16	549	57,732	109,391	Jul 23 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jul 22 '24	Sale	105.16	2,638	277,410	210,377	Jul 23 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jul 22 '24	Sale	105.16	815	85,704	207,457	Jul 23 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jul 15 '24	Sale	111.66	5,496	613,672	207,855	Jul 17 09:05 PM
Sheena Jonathan	CO-FOUNDER	Jul 01 '24	Sale	108.87	2,700	293,945	301,808	Jul 02 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jul 01 '24	Sale	108.37	2,723	295,080	206,772	Jul 02 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jul 01 '24	Sale	108.10	37,500	4,053,805	213,351	Jul 02 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jul 01 '24	Sale	108.37	4,983	539,987	75,059	Jul 02 09:05 PM
Sheena Jonathan	CO-FOUNDER	Jun 18 '24	Sale	109.66	2,700	296,080	304,508	Jun 21 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jun 17 '24	Sale	111.61	6,105	681,372	213,351	Jun 18 09:35 PM
Marcus Gail Boxer	Director	May 30 '24	Sale	110.17	2,000	220,330	18,634	May 31 09:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	May 28 '24	Sale	109.96	1,647	181,103	114,186	May 30 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	May 28 '24	Sale	109.96	1,438	158,122	109,940	May 30 09:05 PM
Chapman Rowan E	Director	May 28 '24	Sale	109.09	4,856	529,728	5,005	May 30 09:05 PM
Sheena Jonathan	CO-FOUNDER	May 23 '24	Sale	108.30	1,000	108,301	68,582	May 24 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	May 15 '24	Sale	107.08	6,779	725,911	219,456	May 17 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	May 10 '24	Option Exercise	19.68	30,000	590,400	234,495	May 10 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	May 10 '24	Sale	104.59	30,000	3,137,567	204,495	May 10 09:35 PM
Sheena Jonathan	CO-FOUNDER	May 10 '24	Sale	105.11	2,700	283,794	319,061	May 10 09:35 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	May 08 '24	Option Exercise	5.40	215,000	1,159,990	1,290,648	May 10 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	May 01 '24	Sale	93.97	1,866	175,344	67,542	May 03 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Apr 29 '24	Sale	93.14	929	86,526	110,748	May 01 09:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Apr 29 '24	Sale	93.14	1,196	111,394	115,833	May 01 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Apr 29 '24	Sale	93.14	1,057	98,448	204,495	May 01 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Apr 29 '24	Sale	93.14	4,084	380,378	226,235	May 01 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 29 '24	Sale	93.14	1,238	115,306	69,408	May 01 09:05 PM
Sheena Jonathan	CO-FOUNDER	Apr 25 '24	Sale	89.55	1,000	89,550	69,082	Apr 26 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 24 '24	Sale	93.00	937	87,140	72,102	Apr 26 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 26 '24	Sale	92.00	751	69,092	70,646	Apr 26 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 25 '24	Sale	89.55	705	63,133	71,397	Apr 26 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Apr 23 '24	Sale	91.38	787	71,915	205,552	Apr 23 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Apr 23 '24	Sale	91.38	531	48,522	117,029	Apr 23 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Apr 23 '24	Sale	91.38	522	47,700	111,677	Apr 23 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Apr 23 '24	Sale	91.38	2,552	233,200	230,319	Apr 23 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 23 '24	Sale	91.38	1,523	139,171	73,039	Apr 23 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Apr 16 '24	Sale	90.82	80,000	7,265,651	117,560	Apr 17 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Apr 15 '24	Sale	93.13	6,816	634,797	227,710	Apr 17 09:05 PM
Sheena Jonathan	CO-FOUNDER	Apr 03 '24	Sale	92.47	26,700	2,468,822	321,031	Apr 04 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 02 '24	Sale	92.62	1,378	127,629	70,646	Apr 04 09:35 PM
Sheena Jonathan	CO-FOUNDER	Mar 28 '24	Sale	90.13	1,000	90,130	69,582	Mar 29 09:35 PM
Sheena Jonathan	CO-FOUNDER	Mar 28 '24	Sale	90.22	447	40,326	347,731	Mar 29 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Mar 28 '24	Sale	90.42	743	67,179	204,839	Mar 29 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Mar 28 '24	Sale	90.42	707	63,924	197,560	Mar 29 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Mar 28 '24	Sale	90.42	464	41,953	112,199	Mar 29 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 15 '24	Sale	89.02	50,910	4,532,065	0	Mar 29 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 28 '24	Sale	90.42	2,662	240,687	234,526	Mar 29 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Mar 28 '24	Sale	90.42	914	82,640	72,024	Mar 29 09:35 PM
BOTHA ROELOF	Director	Mar 15 '24	Option Exercise	42.17	19,924	840,197	20,276	Mar 15 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 15 '24	Option Exercise	19.37	68,270	1,322,406	315,227	Mar 15 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 15 '24	Sale	88.96	83,223	7,403,534	232,004	Mar 15 09:05 PM
Sheena Jonathan	CO-FOUNDER	Mar 06 '24	Sale	88.70	5,000	443,492	458,585	Mar 07 09:40 PM
Sheena Jonathan	CO-FOUNDER	Mar 05 '24	Sale	88.36	1,028	90,839	463,585	Mar 07 09:40 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Mar 05 '24	Sale	88.36	2,160	190,868	204,218	Mar 07 09:40 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 05 '24	Sale	88.36	9,326	824,092	246,957	Mar 07 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Mar 05 '24	Sale	88.36	2,826	249,719	70,646	Mar 07 09:40 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Mar 05 '24	Sale	88.36	2,245	198,361	198,267	Mar 07 09:40 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Mar 05 '24	Sale	88.36	1,838	162,400	112,663	Mar 07 09:40 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Mar 05 '24	Sale	87.40	190,000	16,605,069	860,036	Mar 07 09:40 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Mar 05 '24	Sale	88.36	1,012	89,416	1,075,648	Mar 07 09:40 PM
Sheena Jonathan	CO-FOUNDER	Feb 29 '24	Sale	86.34	10,000	863,433	463,585	Mar 01 08:45 PM
Sheena Jonathan	CO-FOUNDER	Feb 29 '24	Sale	90.02	6,000	540,109	14,655	Mar 01 08:45 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 27 '24	Option Exercise	10.16	35,307	358,802	239,525	Feb 29 09:15 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 29 '24	Option Exercise	9.29	20,526	190,687	224,744	Feb 29 09:15 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 27 '24	Sale	75.09	35,307	2,651,298	204,218	Feb 29 09:15 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 29 '24	Sale	89.01	20,526	1,826,970	204,218	Feb 29 09:15 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Feb 23 '24	Option Exercise	2.66	380,036	1,009,718	1,050,036	Feb 23 09:40 PM
ROSENMAN HERM	Director	Feb 16 '24	Option Exercise	2.66	93,901	249,486	155,586	Feb 16 09:45 PM
ROSENMAN HERM	Director	Feb 16 '24	Sale	69.37	93,901	6,514,371	61,685	Feb 16 09:45 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Feb 06 '24	Option Exercise	16.61	34,029	565,063	104,675	Feb 08 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Feb 06 '24	Sale	70.03	34,029	2,383,129	70,646	Feb 08 09:40 PM
Sheena Jonathan	CO-FOUNDER	Feb 06 '24	Sale	70.00	6,000	420,011	18,155	Feb 08 09:05 PM
Sheena Jonathan	CO-FOUNDER	Feb 07 '24	Sale	70.10	5,000	350,486	473,585	Feb 08 09:05 PM
Sheena Jonathan	CO-FOUNDER	Feb 07 '24	Sale	70.10	1,000	70,099	17,655	Feb 08 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Feb 01 '24	Sale	67.73	22,281	1,509,081	70,646	Feb 02 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jan 29 '24	Sale	65.09	3,235	210,570	92,927	Jan 30 09:15 PM
Sheena Jonathan	CO-FOUNDER	Jan 29 '24	Sale	65.09	546	35,540	478,585	Jan 30 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jan 29 '24	Sale	65.09	4,265	277,614	204,218	Jan 30 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jan 29 '24	Sale	65.09	14,813	964,194	246,957	Jan 30 09:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NTRA

Natera Inc

Upgrade your FINVIZ experience